Anticonvulsant and neuroprotective effect of (S)-3,4-dicarboxyphenylglycine against seizures induced in immature rats by homocysteic acid
Jazyk angličtina Země Velká Británie, Anglie Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
18191956
DOI
10.1016/j.neuropharm.2007.11.015
PII: S0028-3908(07)00375-9
Knihovny.cz E-zdroje
- MeSH
- antikonvulziva terapeutické užití MeSH
- benzoáty terapeutické užití MeSH
- časové faktory MeSH
- chování zvířat účinky léků MeSH
- elektroencefalografie metody MeSH
- fluoresceiny MeSH
- glycin analogy a deriváty terapeutické užití MeSH
- homocystein analogy a deriváty MeSH
- krysa rodu Rattus MeSH
- lékové interakce MeSH
- mozek účinky léků patologie MeSH
- náhodné rozdělení MeSH
- novorozená zvířata MeSH
- organické látky MeSH
- potkani Wistar MeSH
- vztah mezi dávkou a účinkem léčiva MeSH
- záchvaty chemicky indukované farmakoterapie patologie MeSH
- zvířata MeSH
- Check Tag
- krysa rodu Rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- 3,4-dicarboxyphenylglycine MeSH Prohlížeč
- antikonvulziva MeSH
- benzoáty MeSH
- fluoresceiny MeSH
- fluoro jade MeSH Prohlížeč
- glycin MeSH
- homocysteic acid MeSH Prohlížeč
- homocystein MeSH
- organické látky MeSH
The present study has examined the anticonvulsant and neuroprotective effect of (S)-3,4-dicarboxyphenylglycine ((S)-3,4-DCPG), a highly selective agonist for subtype 8 of group III metabotropic glutamate receptors (mGluRs), against seizures induced in immature 12-day-old rats by bilateral icv infusion of DL-homocysteic acid (DL-HCA, 600 nmol/side). For biochemical analyses, rat pups were sacrificed during generalized clonic-tonic seizures, approximately 45-50 min after infusion. Comparable time intervals were used for sacrificing the animals which had received (S)-3,4-DCPG (0.25 nmol/each side, 15-20 min prior to infusion of DL-HCA or saline). This agonist provided a pronounced anticonvulsant effect, generalized clonic-tonic seizures were completely suppressed and cortical energy metabolite changes which normally accompany these seizures were either normalized (decrease of glucose and glycogen) or markedly reduced (an accumulation of lactate). Anticonvulsant effect of (S)-3,4-DCPG was also evident from the EEG recordings, nevertheless, it was not complete. In spite of the absence of obvious motor phenomena, sporadic ictal activity could be seen in some animals. Isolated spikes could also be observed in some animals after administration of (S)-3,4-DCPG alone. The neuroprotective effect of (S)-3,4-DCPG was evaluated after 24 h and 6 days of survival following DL-HCA-induced seizures. Massive neuronal degeneration was observed in a number of brain regions following infusion of DL-HCA alone (seizure group), whereas pretreatment with (S)-3,4-DCPG provided substantial neuroprotection. The present findings suggest that receptor subtype 8 of group III mGluRs may be considered a promising target for drug therapy in childhood epilepsies in the future.
Citace poskytuje Crossref.org
Sulforaphane Ameliorates Metabolic Changes Associated With Status Epilepticus in Immature Rats